Oral administration of heat-killed Lactobacillus pentosus strain b240 augments protection against influenza virus infection in mice

International Immunopharmacology

Volumn 11, Issue 2, 2011, Pages 199-203

  Kobayashi, Noritada ^a   Saito, Takao ^b   Uematsu, Takayuki ^a   Kishi, Kazumasa ^b   Toba, Masamichi ^b   Kohda, Noriyuki ^b   Suzuki, Tatsuo ^a  

^a KITASATO UNIVERSITY MEDICAL CENTER   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Immunoglobulin A; Influenza virus; Lactobacillus pentosus strain b240; Mice

Indexed keywords

B 240; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROBIOTIC AGENT; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BACTERIAL STRAIN; BAGG ALBINO MOUSE; CONTROLLED STUDY; FEEDING; FEMALE; HEAT; IMMUNE RESPONSE; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; LACTOBACILLUS; LACTOBACILLUS PENTOSUS; LUNG LAVAGE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALIVATION; SPLEEN CELL; SURVIVAL TIME; TREATMENT DURATION;

ADMINISTRATION, ORAL; ANIMALS; CELL LINE; DOGS; EPITHELIAL CELLS; FEMALE; HOT TEMPERATURE; IMMUNITY, CELLULAR; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLUENZA A VIRUS, H1N1 SUBTYPE; LACTOBACILLUS; LUNG; LYMPHOCYTES; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS;

EID: 79151477499     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.11.019     Document Type: Article

References (31)

1. Monto A.S. Seasonal influenza and vaccination coverage Vaccine 26 Sup 4 2008 D45 D48
2. Van der Wouden J.C., Bueving H.J., and Poole P. Preventing influenza: an overview of systematic reviews Respir Med 99 2005 1341 1349
3. Oxford J.S., Bossuyt S., Balasingam S., Mann A., Novelli P., and Lambkin R. Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors Clin Microbiol Infect 9 2003 1 14
4. Long J.K., Mossad S.B., and Goldman M.P. Antiviral agents for treating influenza Cleve Clin J Med 67 2000 92 95
5. Jones M., and Mar C.D. Safety of neuraminidase inhibitors for influenza Expert Opin Drug Saf 5 2006 603 608
6. J. Beigel, and M. Bray Current and future antiviral therapy of severe seasonal and avian influenza Antiviral Res 78 2008 91 102
7. S. Tamura, H. Asanuma, Y. Ito, Y. Hirabayashi, Y. Suzuki, and T. Nagamine Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza HA vaccine Eur J Immunol 22 1992 477 481
8. Renegar K.B., Small P.A., Boykins L.G. Jr., and Wright P.F. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract J Immunol 173 2004 1978 1986
9. A. Takada, S. Matsushita, A. Ninomiya, Y. Kawaoka, and H. Kida Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice Vaccine 21 2003 3212 3218
10. S. Tamura, and T. Kurata Defense mechanisms against influenza virus infection in the respiratory tract mucosa Jpn J Infect Dis 57 2004 236 247
11. Brandtzaeg P. Induction of secretory immunity and memory at mucosal surfaces Vaccine 25 2007 5467 5484
12. Mossad S.B. Demystifying FluMist, a new intranasal, live influenza vaccine Cleve Clin J Med 70 2003 801 806
13. Yamahira S., Toba M., Kishi K., and Okamatsu H. Stimulation of mucosal immune system by lactic acid bacteria originating in tea Jpn J Lactic Acid Bact 17 2006 57 60 (in Japanese)
14. K. Kishi, Y. Kotani, S. Yamahira, M. Toba, H. Okamatsu, and S. Mihara Lactobacillus plantarum ONRIC b0240 enhanced salivary IgA in healthy volunteers Jpn J Lactic Acid Bact 17 2006 132 137 (in Japanese)
15. Y. Kotani, S. Shinkai, H. Okamatsu, M. Toba, K. Ogawa, and H. Yoshida Oral intake of Lactobacillus pentosus strain b240 accelerates salivary immunoglobulin A secretion in the elderly: a randomized, placebo-controlled, double-blind trial Immun Ageing 7 2010 11
16. H. Ishikawa, E. Kutsukake, T. Fukui, I. Sato, T. Shirai, and T. Kurihara Oral administration of heat-killed Lactobacillus plantarum strain b240 protected mice against Salmonella enterica Serovar Typhimurium Biosci Biotechnol Biochem 74 2010 1338 1342
17. S. Okada, W. Daengsubha, T. Uchimura, N. Ohara, and M. Kozaki Flora of lactic acid bacteria in Miang produced in northern Thailand J Gen Appl Microbiol 32 1986 57 65
18. Bringel F., Castioni A., Olukoya D.K., Felis G.E., Torriani S., and Dellaglio F. Lactobacillus plantarum subsp. argentoratensis subsp. nov., isolated from vegetable matrices Int J Syst Evol Microbiol 55 2005 1629 1634
19. Reed L.J., and Münch H. A simple method for estimating fifty percent endpoints Am J Hygiene 27 1968 493 497
20. K. Tobita, A. Sugiura, C. Enomote, and M. Furuyama Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin Med Microbiol Immunol 162 1975 9 14
21. H. Yasui, J. Kiyoshima, T. Hori, and K. Shida Protection against influenza virus infection of mice fed Bifidobacterium breve YIT4064 Clin Diagn Lab Immunol 6 1999 186 192
22. Salva S., and Villena Jujio Alvarez S. Immunomodulatory activity of Lactobacillus rhamnosus strains isolated from goat milk: impact on intestinal and respiratory infections Int J Food Microbiol 141 2010 82 89
23. T. Hori, J. Kiyoshima, K. Shida, and H. Yasui Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota Clin Diagn Lab Immunol 9 2002 105 108
24. Yasui H., Kiyoshima J., and Hori T. Reduction of influenza virus titer and protection against influenza virus. infection in infant mice fed Lactobacillus casei Shirota Clin Diagn Lab Immunol 11 2004 675 679
25. N. Maeda, R. Nakamura, Y. Hirose, S. Murosaki, Y. Yamamoto, and T. Kase Oral administration of heat-killed Lactobacillus plantarum L-137 enhances protection against influenza virus infection by stimulation of type I interferon production in mice Int Immunopharmacol 9 2009 1122 1125
26. H. Yamada, and T. Nagai In vivo anti-influenza virus activity of kampo (Japanese herbal) medicine "sho-seiryu-to" and its mode of action Int J Immunopharmacol 16 1994 605 613
27. H. Kiyohara, T. Nagai, K. Munakata, K. Nonaka, T. Hanawa, and S.J. Kim Stimulating effect of Japanese herbal (kampo) medicine, hochuekkito on upper respiratory mucosal immune system Evid Based Complement Alternat Med 3 2006 459-46
28. Mori K., Kido T., Daikuhara H., Sakakibara I., Sakata T., and Shimizu K. Effect of Hochu-ekki-to (TJ-41), a Japanese herbal medicine, on the survival of mice infected with influenza virus Antiviral Res 44 1999 103 111
29. Kamijuku H., Nagata Y., Jiang X., Ichinohe T., Tashiro T., and Mori K. Mechanism of NKT cell activation by intranasal coadministration of alpha-galactosylceramide, which can induce cross-protection against influenza viruses Mucosal Immunol 1 2008 208 218
30. Y.-T. Tsai, P.-C. Cheng, J.-W. Liao, and T.-M. Pan Effect of the administration of Lactobacillus paracasei subsp. paracasei NTU 101 on Peyer's patch-mediated mucosal immunity Int Immunopharmacol 10 2010 791 798
31. Boivin G., Goyette N., Hardy I., Aoki F., Wagner A., and Trottier S. Rapid antiviral effect of inhaled Zanamivir in the treatment of naturally occurring influenza in otherwise healthy adults J Infect Dis 181 2000 1471 1474